Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Another Call for Better Risk Stratification in Cardiac Imaging

This article was originally published in Start Up

Executive Summary

New data showing that the slightly more than one-third of patients with previously unconfirmed coronary artery disease who go to the cath lab for invasive angiography testing actually have an obstructive blockage are sure to ratchet up the already active discussions around the appropriate use of cardiac imaging - both from the effectiveness and safety perspectives. Part of the solution may be the development of molecular IVD tests aimed at triaging patients to imaging. Even if slow to integrate this brand of R&D into their development strategies, some makers of in vivo imaging equipment are beginning to realize this.
Advertisement

Related Content

GE Acquires Clarient To Anchor Its Molecular IVD Business
Radiation Safety Concerns Could Drive New Legislation, Quality Standards
Radiation Safety Concerns Could Drive New Legislation, Quality Standards
CardioDx: Bringing Molecular Diagnostics Into the Cardiovascular Arena
CardioDx: Bringing Molecular Diagnostics Into the Cardiovascular Arena
CardioDx: Bringing Molecular Diagnostics Into the Cardiovascular Arena
The Pace of Development of Molecular Imaging Agents
The Pace of Development of Molecular Imaging Agents
Profiles of COURAGE: Another Speed Bump for Stents or Flawed Trial?

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT037661

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel